TY - JOUR
T1 - Chronic kidney disease
T2 - Global dimension and perspectives
AU - Jha, Vivekanand
AU - Garcia-Garcia, Guillermo
AU - Iseki, Kunitoshi
AU - Li, Zuo
AU - Naicker, Saraladevi
AU - Plattner, Brett
AU - Saran, Rajiv
AU - Wang, Angela Yee Moon
AU - Yang, Chih Wei
PY - 2013
Y1 - 2013
N2 - Summary Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated to be 8-16% worldwide. Complications include increased all-cause and cardiovascular mortality, kidney-disease progression, acute kidney injury, cognitive decline, anaemia, mineral and bone disorders, and fractures. Worldwide, diabetes mellitus is the most common cause of chronic kidney disease, but in some regions other causes, such as herbal and environmental toxins, are more common. The poorest populations are at the highest risk. Screening and intervention can prevent chronic kidney disease, and where management strategies have been implemented the incidence of end-stage kidney disease has been reduced. Awareness of the disorder, however, remains low in many communities and among many physicians. Strategies to reduce burden and costs related to chronic kidney disease need to be included in national programmes for non-communicable diseases.
AB - Summary Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated to be 8-16% worldwide. Complications include increased all-cause and cardiovascular mortality, kidney-disease progression, acute kidney injury, cognitive decline, anaemia, mineral and bone disorders, and fractures. Worldwide, diabetes mellitus is the most common cause of chronic kidney disease, but in some regions other causes, such as herbal and environmental toxins, are more common. The poorest populations are at the highest risk. Screening and intervention can prevent chronic kidney disease, and where management strategies have been implemented the incidence of end-stage kidney disease has been reduced. Awareness of the disorder, however, remains low in many communities and among many physicians. Strategies to reduce burden and costs related to chronic kidney disease need to be included in national programmes for non-communicable diseases.
UR - http://www.scopus.com/inward/record.url?scp=84880511470&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(13)60687-X
DO - 10.1016/S0140-6736(13)60687-X
M3 - 文献综述
C2 - 23727169
AN - SCOPUS:84880511470
SN - 0140-6736
VL - 382
SP - 260
EP - 272
JO - The Lancet
JF - The Lancet
IS - 9888
ER -